Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT05735496
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
219
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
TQB2102 injection
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.